Within the Schmidt group, I work as a project coordinator on several national and international research initiatives in genetic epidemiology, cancer risk prediction and prevention.
I coordinate Hebon, the national cohort and research infrastructure for hereditary and familial breast and ovarian cancer in the Netherlands. Hebon combines genetic, clinical, registry and questionnaire data to facilitate research into cancer risks, risk factors, prevention and early detection.
I also coordinate HER-CARE, a European Marie Skłodowska-Curie doctoral network focused on hereditary and early-onset cancer. HER-CARE brings together 15 PhD students across Europe, combining research and training to improve our understanding of cancer risk and contribute to better risk assessment, prevention and care.
Within the Joint Action on Personalised Cancer Medicine (JA-PCM), I support the coordination of a pilot on the implementation of polygenic risk scores in cancer screening.
My background is in health sciences and epidemiology. I obtained my PhD from Vrije Universiteit Amsterdam in 2020, conducting my research at Sanquin and Amsterdam UMC on the associations between lifestyle and environmental factors and blood parameters in blood donors.